0
JAMA Patient Page |

Cancer Clinical Trials FREE

Sharon Parmet, MS, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2004;291(22):2778. doi:10.1001/jama.291.22.2778.
Text Size: A A A
Published online

Clinical trials are used to evaluate tests or treatments that have not yet been proven to be effective. Clinical trials rely on volunteers to take part in them. The June 9, 2004, issue of JAMA includes an article about patients who participate in cancer clinical trials.

PHASES OF TREATMENT TRIALS

  • Phase 1 trials are conducted to determine if a new treatment is safe and what doses can be given and to discover the main adverse effects of the new treatment. At this first phase, a small number of patients are enrolled.

  • Phase 2 trials further evaluate the safety and potential effectiveness of a therapy and evaluate how it affects the body.

  • Phase 3 trials provide scientific testing of the value of a new treatment. Participants are randomly (by chance, like flipping a coin) assigned to receive the new therapy, the current standard therapy, or a placebo (an inactive pill or procedure). Most new therapies move on to phase 3 trials only if they have shown promise during phase 1 and phase 2 trials.

  • Phase 4 trials evaluate the long-term safety of the new treatment and take place after the new treatment has been approved for use.

ELIGIBILITY TO PARTICIPATE IN A CLINICAL TRIAL

Every clinical trial has guidelines that outline who can and cannot participate in the study. These guidelines are called eligibility criteria. Cancer clinical trials usually require that patients have a particular type or stage of cancer to participate.

INFORMED CONSENT

Patients who wish to enroll in a clinical trial must give informed consent before participating. Informed consent ensures that patients understand the potential risks and benefits of joining a clinical trial prior to participating. During the informed consent process, participants are told about what the trial involves and the purpose of the study. Participants sign an informed consent form to acknowledge that they understand the risks and benefits of the study, but the form is not binding, and participants can leave the study at any time for any reason.

BENEFITS OF PARTICIPATING IN A CLINICAL TRIAL

  • Participants may receive promising new therapies that are not available to the public.

  • Participants are closely monitored by researchers, doctors, and other health care professionals during the clinical trial.

  • Results from the clinical trial may help other patients in the future.

RISKS OF PARTICIPATING IN A CLINICAL TRIAL

  • New therapies are not always better than standard treatments with which they are compared.

  • New treatments may have unexpected adverse effects or risks.

  • Participants in randomized trials may not receive the therapy they want.

  • Health insurance may not cover all of the costs associated with participating in a clinical trial. Disclosure about any costs should be part of the informed consent.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and other JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on participating in medical research was published in the February 7, 2001, issue.

Sources: National Cancer Institute's Cancer Information Service

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.

TOPIC: CANCER

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Cancer, Family History

The Rational Clinical Examination
Original Article: Does This Patient Have a Family History of Cancer?